0001042167-24-000039.txt : 20240517 0001042167-24-000039.hdr.sgml : 20240517 20240517194140 ACCESSION NUMBER: 0001042167-24-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240515 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEINER MITCHELL SHUSTER CENTRAL INDEX KEY: 0001276244 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13602 FILM NUMBER: 24962047 MAIL ADDRESS: STREET 1: 175 TOYOTA PLAZA STREET 2: 7TH FLOOR CITY: MEMPHIS STATE: TN ZIP: 38103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERU INC. CENTRAL INDEX KEY: 0000863894 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 391144397 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 2916 N. MIAMI AVENUE STREET 2: SUITE 1000 CITY: MIAMI STATE: FL ZIP: 33127 BUSINESS PHONE: 3125959123 MAIL ADDRESS: STREET 1: 2916 N. MIAMI AVENUE STREET 2: SUITE 1000 CITY: MIAMI STATE: FL ZIP: 33127 FORMER COMPANY: FORMER CONFORMED NAME: FEMALE HEALTH CO DATE OF NAME CHANGE: 19960205 FORMER COMPANY: FORMER CONFORMED NAME: WISCONSIN PHARMACAL COMPANY INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-05-15 0 0000863894 VERU INC. VERU 0001276244 STEINER MITCHELL SHUSTER 2916 NORTH MIAMI AVENUE SUITE 1000 MIAMI FL 33127 1 1 0 0 President and CEO 0 Common Stock 2024-05-15 4 S 0 84021 1.4974 D 7100746 D Common Stock 2024-05-16 4 S 0 59788 1.4071 D 7040958 D Common Stock 2024-05-17 4 S 0 28066 1.3179 D 7012892 D Common Stock 144000 I Footnote Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 1.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,686,180 shares, and will continue to be the Company's second largest shareholder. The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.4800 to $1.5200. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.3800 to $1.4650. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.3000 to $1.3450. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. Shares are held by four individual trusts with each trust for the benefit of an adult child of the reporting person. The reporting person is the trustee of each of the trusts. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose. /s/ Phil R. Greenberg, via Power of Attorney 2024-05-17